Hosted on MSN
FDA pilots AI tools to speed cancer trial reviews
The FDA has launched two proof-of-concept studies to test real-time safety data feeds in cancer trials and is seeking input on using AI to optimize early-phase research. One AstraZeneca trial has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results